These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 812183)

  • 21. Effects of therapy with dialyzable leukocyte extracts containing transfer factor activity on antibody-dependent cytotoxic activity in humans.
    Nékám K; Láng I; Török K; Kalmár L; Gergely P; Petrányi G
    Clin Immunol Immunopathol; 1979 Aug; 13(4):407-12. PubMed ID: 226302
    [No Abstract]   [Full Text] [Related]  

  • 22. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts).
    Schindler TE; Baram P
    Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 24. Transfer-factor therapy of malignancy.
    Neidhart JA; LoBuglio AF
    Semin Oncol; 1974 Dec; 1(4):379-85. PubMed ID: 4220127
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of immunity of schistosomiasis: histopathologic study of lesions elicited in rhesus monkeys during immunizations and challenge with cercariae of Schistosoma japonicum.
    Hsü SY; Hsü HF; Penick GD; Lust GL; Osborne JW; Cheng HF
    J Reticuloendothel Soc; 1975 Sep; 18(3):167-85. PubMed ID: 811795
    [No Abstract]   [Full Text] [Related]  

  • 26. COMPARATIVE OBSERVATIONS ON EXPERIMENTAL SCHISTOSOMA MANSONI INFECTIONS IN AFRICAN GREEN AND RHESUS MONKEYS.
    MEISENHELDER JE; THOMPSON PE
    J Parasitol; 1963 Aug; 49():568-70. PubMed ID: 14050232
    [No Abstract]   [Full Text] [Related]  

  • 27. [CONSIDERATIONS ON THE VARIOUS SCHISTOSOMAL ELEMENTS FOUND IN MACACA MULATTA AND MICE EXPERIMENTALLY INFECTED WITH SCHISTOSOMA MANSONI].
    OLIVEIRA CA; PELLEGRINO J; DA CUNHA AS; ALVARENGA RJ
    Rev Inst Med Trop Sao Paulo; 1963; 5():249-56. PubMed ID: 14110098
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of infection intensity of Schistosoma mansoni on resistance against existing and subsequent infections in Macaca mulatta.
    Ritchie LS; Knight WB; McMullen DB; Von Lichtenberg F
    Am J Trop Med Hyg; 1966 Jan; 15(1):43-9. PubMed ID: 4955007
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy using the transfer factor in combined immunologic deficiency syndromes].
    Dienst C; Waldschmidt R; Mueller-Eckhardt C
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1810-2. PubMed ID: 1030113
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Schistosoma mansoni on plasma cholinesterase activity in rhesus monkeys.
    Hass DK
    Experientia; 1976 Nov; 32(11):1390-1. PubMed ID: 825382
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotactic activity in dialyzable transfer factor.
    Gallin JI; Kirkpatrick CH
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):498-502. PubMed ID: 4205594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations on therapeutic and prophylatic effects by homologous immune blood against Schistosoma mansoni in Rhesus monkeys.
    MEISENHELDER JE; OLSZEWSKI B; THOMPSON PE
    J Parasitol; 1960 Oct; 46():645-7. PubMed ID: 13769095
    [No Abstract]   [Full Text] [Related]  

  • 33. Transfer factor and its clinical application.
    Schulkind ML; Ayoub EM
    Adv Pediatr; 1980; 27():89-115. PubMed ID: 7013447
    [No Abstract]   [Full Text] [Related]  

  • 34. Resistance to experimental infection with Schistosoma mansoni in rhesus monkeys induced by the transfer of adult worms.
    Smithers SR; Terry RJ
    Trans R Soc Trop Med Hyg; 1967; 61(4):517-33. PubMed ID: 4964088
    [No Abstract]   [Full Text] [Related]  

  • 35. [A new approach to immunotherapy: the transfer factor].
    Di Padova F
    Minerva Med; 1979 May; 70(25):1773-85. PubMed ID: 379697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cell-mediated responses with dialyzable leukocyte extract containing transfer factor.
    Klesius PH
    Adv Exp Med Biol; 1981; 137():293-323. PubMed ID: 6174037
    [No Abstract]   [Full Text] [Related]  

  • 38. Dialyzable leukocyte extract therapy in immunodepressed patients with cutaneous leishmaniasis.
    Delgado O; Romano EL; Belfort E; Pifano F; Scorza JV; Rojas Z
    Clin Immunol Immunopathol; 1981 Jun; 19(3):351-9. PubMed ID: 7249417
    [No Abstract]   [Full Text] [Related]  

  • 39. Schistosoma mansoni in Macaca mulatta. Long-term studies on the course of primary and challenge infections.
    McMullen DB; Ritchie LS; Oliver-González J; Knight WB
    Am J Trop Med Hyg; 1967 Sep; 16(5):620-7. PubMed ID: 4964092
    [No Abstract]   [Full Text] [Related]  

  • 40. Chorioretinitis with a combined defect in T and B lymphocytes and granulocytes. A new syndrome successfully treated with dialyzable leukocyte extracts (transfer factor).
    Kyong CU; Wilson GB; Fudenberg HH; Goust JM; Richardson P; Echerd J
    Am J Med; 1980 Jun; 68(6):955-61. PubMed ID: 6992573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.